Fred Hutch at ASH: Latest CAR T Data - BCMA, CD19, CD20 - Plus New Insights on Transplantation, Gene Therapy - and More
November 21, 2019
November 21, 2019
SEATTLE, Washington, Nov. 21 -- The Fred Hutchinson Cancer Research Center issued the following news release:
Fred Hutchinson Cancer Research Center's latest findings on CAR (chimeric antigen receptor) T-cell therapy, gene therapy, precision oncology, immune repair and transplantation will be featured at the 61st American Society of Hematology Annual Meeting and Exposition, which will be held Dec. 7-10 in Orlando, Florida.
Fred Hutch transplantation physician-scientist . . .
Fred Hutchinson Cancer Research Center's latest findings on CAR (chimeric antigen receptor) T-cell therapy, gene therapy, precision oncology, immune repair and transplantation will be featured at the 61st American Society of Hematology Annual Meeting and Exposition, which will be held Dec. 7-10 in Orlando, Florida.
Fred Hutch transplantation physician-scientist . . .